BrainsWay at an all-time high on Q4 beat, upside guidance
Source: SeekingAlpha
2026-03-11 13:17:38 ET
More on BrainsWay
- BrainsWay Ltd. (BWAY) Q4 2025 Earnings Call Transcript
- BrainsWay GAAP EPS of $0.07 beats by $0.04, revenue of $14.55M beats by $0.53M
- Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag
- Seeking Alpha’s Quant Rating on BrainsWay
- Historical earnings data for BrainsWay
Read the full article on Seeking Alpha
For further details see:
BrainsWay at an all-time high on Q4 beat, upside guidance
BrainsWay Ltd.
NASDAQ: BWAY
BWAY Trading
-2.01% G/L:
$13.64 Last:
221,310 Volume:
$13.80 Open:
BWAY Latest News
March 11, 2026 07:30:00 am
BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
March 04, 2026 07:30:00 am
Landmark Data Validate BrainsWay's SWIFT(TM) Deep TMS, Beginning a New Era in Depression Treatment
February 25, 2026 08:00:00 am
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026
BWAY Stock Data
$449,653,703
18,680,536
N/A
14
N/A
Medical Equipment & Supplies
Healthcare
IL
Jerusalem
